The age-old advice to "trust your gut" could soon take on new meaning for people diagnosed with Parkinson's disease, thanks ...

Mouse models of GBA1 Parkinson’s disease that are treated with Gain Therapeutics’ clinical-stage drug appear to have better cognitive function and lower disease biomarkers than untreated animals. The ...

In the late 1960s, scientists discovered a miracle drug for Parkinson’s disease — a simple, inexpensive dopamine-replacement ...

A new drug has shown promise in combating Parkinson’s disease while minimizing unwanted side effects. The once-daily pill, tavapadon, was found to relieve symptoms — including stiffness, coordination, ...

Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s disease and Parkinson’s in a new collaboration which aims to discover ...

Boston, Oct. 16, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Anti-Parkinson's Drugs: Global Markets to 2030” is projected to grow from $6.1 billion in 2025 to $9.2 ...

Symptoms of Parkinson’s disease, such as tremors and stiffness, can make daily tasks difficult. A new drug has shown promise in alleviating symptoms. Tavapadon, a drug being tested to treat early ...

NEW YORK (Reuters Health) - Nearly every prescription written to treat Parkinson's psychosis -- a common psychiatric side effect of Parkinson's disease -- is for medications that have not been shown ...

The U.S. Food and Drug Administration approved Nuplazid (pimavanserin) tablets last week as the first approved drug to treat hallucinations and delusions associated with psychosis experienced by some ...